Abiopharma

🔍 Foster Mark E. (Executive)

Company: American Healthcare REIT, Inc. (AHR)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 2,000 shares of Common Stock at $55.39 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 51,617.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
• F2: The transaction described herein was made pursuant to an exception to a lock-up agreement between the Reporting Person and the underwriters of the Issuer's offering of shares of common stock that closed on August 12, 2026.
• F3: Includes 622 shares acquired under the Issuer's Employee Stock Purchase Plan.